Claims for Patent: 7,795,263

Summary for Patent: 7,795,263

Title:	Pharmaceutical combination for and method of anesthetizing and immobilizing non-domesticated mammals
Abstract:	Non-domesticated mammalian animals are anesthetized and immobilized by injecting an effective amount of an anesthetizing and immobilizing drug comprising pharmaceutically active ingredients of butorphanol tartrate, azaperone tartrate and medetomidine hydrochloride (BAM) into the animal from a dart. The BAM combination is preferably initially formed as lyophilized powder of the pharmaceutically active ingredients, and then reconstituted before injection as an injectable liquid in the environment of the animal.
Inventor(s):	Lance; William R. (Fort Collins, CO), Wolfe; Lisa L. (Fort Collins, CO)
Assignee:	Wildlife Laboratories, Inc. (Fort Collins, CO)
Application Number:	12/169,446
Patent Claims:	1. A pharmaceutical combination capable of reversibly anesthetizing and immobilizing free-ranging non-domesticated mammalian animals, consisting essentially of butorphanol tartrate, azaperone tartrate and medetomidine hydrochloride combined in solution for a single intramuscular injection having a relative weight ratio relationship of 14-55 mg/ml of butorphanol tartrate and 9-36 mg/ml of azaperone tartrate and 5-22 mg/ml of medetomidine hydrochloride. 2. A pharmaceutical combination as defined in claim 1, wherein the approximate relative weight ratio relationship of the pharmaceutically active ingredients is 27 mg/ml of butorphanol tartrate, 18 mg/ml of azaperone tartrate, and 11 mg/ml of medetomidine hydrochloride. 3. A pharmaceutical combination as defined in claim 1, wherein the injectable volume of the solution is no more than 3 milliliters. 4. A pharmaceutical combination as defined in claim 1, wherein the butorphanol tartrate, azaperone tartrate and medetomidine hydrochloride are lyophilized as a powder before injection. 5. A pharmaceutical combination as defined in claim 4, wherein the lyophilized powder is formulated into the injectable solution by the addition of sterile water. 6. A method of making the pharmaceutical combination defined in claim 1, comprising combining predetermined quantities of solutions of the butorphanol tartrate, the azaperone tartrate and the medetomidine hydrochloride. 7. A method as defined in claim 6, further comprising lyophilizing the butorphanol tartrate, the azaperone tartrate and the medetomidine hydrochloride from the solutions to form a powder. 8. A method as defined in claim 6, wherein the approximate relative weight ratio relationship is 27 mg/ml of butorphanol tartrate, 18 mg/ml of azaperone tartrate, and 11 mg/ml of medetomidine hydrochloride. 9. A method of anesthetizing and immobilizing free-ranging non-domesticated mammalian animals by injecting an effective amount of the pharmaceutical combination defined in claim 1 into the animal from a dart which is projected in a trajectory to the animal. 10. A method as defined in claim 9, further comprising projecting the dart into the animal in a trajectory of up to 70 meters. 11. A method as defined in claim 9, further comprising delivering a volume of the pharmaceutical combination to the animal which is no greater than 3 milliliters by the dart. 12. A method as defined in claim 11, further comprising injecting an animal which has a minimum weight of at least 20 kilograms. 13. A method as defined in claim 9, wherein an approximate relative weight ratio relationship of the pharmaceutically active ingredients is 27 mg/ml of butorphanol tartrate, 18 mg/ml of azaperone tartrate, and 11 mg/ml of medetomidine hydrochloride. 14. A method as defined in claim 9, further comprising constituting the solution from a lyophilized powder of butorphanol tartrate, azaperone tartrate and medetomidine hydrochloride by adding sterile water to the powder. 15. A method as defined in claim 14, further comprising adding the sterile water to the powder in the environment in which the animal is present before injecting the animal. 16. A method as defined in claim 9, further comprising substantially reversing the anesthesia and immobilization by injecting the animal with antagonists of the butorphanol tartrate and the medetomidine hydrochloride.

Details for Patent 7,795,263

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	ZOSTAVAX	zoster vaccine live	For Injection	125123	05/25/2006		2039-09-22